1.Construction of recombinant adenoviruses carrying human urokinase-type plasminogen activator and its expression in hepatic stellate cells in vitro.
Weifen XIE ; Yong LIN ; Xin ZHANG ; Zhongbing ZHANG ; Weizhong CHEN ; Zhihong CHENG ; Yuexiang CHEN ; Xingrong ZHANG
Chinese Journal of Hepatology 2002;10(5):383-383
2.Construction of the recombinant adenovirus carrying sodium/iodide symporter gene.
Rui HUANG ; An'ren KUANG ; Haifang YU ; Chao MA ; Gongshun TANG
Journal of Biomedical Engineering 2005;22(4):765-768
Human Sodium/Iodide symporter gene cDNA was amplified from thyroid tissue of the patient suffering from Graves disease by RT-PCR, and T/A cloned into pGEM-TEasy-NIS for sequencing, subcloned into shuttle plasmid pAdTrack-CMV which contained a green fluorescent protein (GFP) gene, and then forwarded to homologous recombinant in the bacteria BJ5183 that already contained AdEasy-1 plasmid. Positive recombinant adenovirus vector was selected, packaged and amplified in the 293 cells to obtain recombinant adenovirus. The results showed that the recombinant AdNIS was correctly constructed and confirmed by restriction enzyme analysis and PCR. The viral titer was 2. 5 - 3 x 10(9) efu/ml. So, the recombinant adenovirus vector carrying hNIS was successfully constructed, thus providing a basis for researches on 131I therapy in nonthyroid carcinoma.
Adenoviridae
;
genetics
;
metabolism
;
DNA, Complementary
;
genetics
;
Genetic Vectors
;
genetics
;
metabolism
;
Graves Disease
;
genetics
;
Green Fluorescent Proteins
;
genetics
;
metabolism
;
Humans
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
Symporters
;
biosynthesis
;
genetics
3.Construction and expression of recombinant adenovirus containing human catalase gene in vitro.
Xiao-ling OU-YANG ; Ai-ling LI ; Qi-lan NING ; Xu-dong YANG ; Nan XU ; Hui-lian WANG
Journal of Zhejiang University. Medical sciences 2011;40(3):291-296
OBJECTIVETo construct the adenovirus vector containing recombinant human catalase (CAT) and to express the recombinant gene in vitro.
METHODSTotal RNA was extracted from human leukocytes and full-length human CAT cDNA was obtained with RT-PCR method. The CAT gene was cloned into pcDNA3.1(+) vector and pcDNA3.1(+)CAT was constructed. The positive clones were confirmed by the restriction enzyme digestion and gene sequencing. The CAT gene was cloned into the entry vector pENTR1A, and pENTR1A-CAT vector was constructed. By LR reaction pENTR1A-CAT and pAd/CMV/V5-DEST was recombined in vitro, and the recombinant adenovirus pAd/CMV/V5-DEST-CAT was obtained. The positive pAd/CMV/V5-DEST-CAT was confirmed by sequencing and transfected into 293A cells with Pac I linearization and Lipofectamine 2 000, and the recombinant virus particles were packaged and amplified in the cells. The expression of CAT protein and CAT enzyme activities of the recombinant virus were determined by Western blot and 240 nm UV absorption methods.
RESULTHigh expression of recombinant adenovirus was obtained and the expressed human catalase had high enzyme activity.
CONCLUSIONAd/CMV/V5-DEST-CAT vector containing human catalase gene has been constructed successfully; and the expressed enzyme in 293A cells has high activity.
Adenoviridae ; genetics ; Catalase ; genetics ; metabolism ; Cell Line ; Genetic Vectors ; Humans ; Transfection
4.Effect of wild-type p53 gene on the number and proteins of centrosome in leukemic K562 cells.
Hong-bin WANG ; Wen-li FENG ; Shi-feng HUANG ; Wen-jun TIAN ; Wei-xi CAO ; Zong-gan HUANG
Chinese Journal of Hematology 2009;30(5):326-331
OBJECTIVETo observe the effect of recombinant adenovirus-mediated wild-type p53 gene on the number and proteins of centrosome in K562 cells. To explore the possibility of application of wild-type p53 gene therapy in the treatment of chronic myeloid leukemia.
METHODSThe recombinant adenoviruses carrying wild-type p53 gene (Ad5 wtp53), mutant p53 gene (Ad5 mtp53) or the green fluorescent protein (GFP) gene was repeatedly amplified and co-infected into K562 cells with cation polybrene. The optimal infection titer and infection time of the recombinant adenoviruses were determined by MTT assay, p53 mRNA and protein expression were determined by RT-PCR and Western blot respectively. The centrosomal structural protein gamma-tubulin and the spindle protein alpha-tubulin were marked simultaneously by indirect immunofluorescence staining, and the expression of the centrosomal gamma-tubulin protein, the mitosis and the number of centrosome were observed under the laser confocal microscopy.
RESULTSInfection efficiency with recombinant adenoviruses was facilitated by polybrene in K562 cells, and 4 microg/ml polybrene was chosen. The optimal adenovirus infection titer was 20,000 MOI and the optimal infection time was 72 hours. p53 mRNA and P53 protein can be expressed in K562 cells by Ad5wtp53 and Ad5mtp53. Both the expression of the centrosomal gamma-tubulin protein and the number of centrosomes were decreased after Ad5wtp53 infection.
CONCLUSIONThere is sustained expression of P53 protein in K562 cells after its infection by Ad5wtp53. Wild-type P53 protein can lead to the down-regulation of the number of centrosomes and the expression of centrosomal gamma-tubulin protein in K562 cells.
Adenoviridae ; genetics ; Centrosome ; metabolism ; Genes, p53 ; genetics ; Genetic Vectors ; Humans ; K562 Cells ; Transfection ; Tubulin ; metabolism ; Tumor Suppressor Protein p53 ; metabolism
5.Construction of a recombinant adenovirus carrying endostatin gene.
Ying MA ; Yuan-Li HE ; Fang YANG
Journal of Southern Medical University 2007;27(10):1514-1516
OBJECTIVETo construct a recombinant adenovirus carrying human endostatin gene with AdEasy system.
METHODSEndostatin gene fragment was amplified from Pshuttle-Endostatin plasmid with PCR and subcloned into the pAdTrack-CMV shuttle vector. The resultant plasimid was cotransduced into E.coli BJ 5183 cells with pAdEasy-1 plasmid for homologous recombination. The linearized recombinant plasmid was subsequently transfected into AAV 293 cells, and the recombinant adenovirus was detected by GFP, PCR and restriction analysis.
RESULTS AND CONCLUSIONThe positive clones of the recombinants were verified by restriction analysis and the titer of the virus reached 2.06 x 10(10)pfu/ml, suggesting successful construction of recombinant adenovirus pAd-Endo.
Adenoviridae ; genetics ; metabolism ; Cell Line ; Cloning, Molecular ; Endostatins ; genetics ; metabolism ; Escherichia coli ; genetics ; metabolism ; Gene Expression ; Genetic Engineering ; Genetic Vectors ; genetics ; metabolism ; Humans
6.In vitro transgenic expression efficacy of a helper-dependent adenoviral vector encoding enhanced green fluorescent protein.
Xianxian ZHENG ; Jinsheng HE ; Yuanhui FU ; Shaohua XU ; Can XIE ; Changxin SHI ; Mei ZHANG ; Xiaobo WANG ; Tao HONG
Chinese Journal of Biotechnology 2010;26(8):1108-1115
To investigate the transgenic expressing efficacy of helper-dependent adenoviral vector (HDAd) in vitro, we constructed a HDAd encoding enhanced green fluorescent protein (EGFP), denominated as HDAd/EGFP, performed large scale preparation and purification, and then identified the purified HDAd/EGFP under fluorescent microscope and electron microscope. After the concentration of HDAd/EGFP was determined by spectrophotometer, the transgenic expression efficiency of HDAd/EGFP was compared with first generation adenoviral vector encoding EGFP (FGAd/EGFP) in vitro. Therefore, we infected A549 cells with 2000 virus particles (vp) per cell by HDAd/EGFP and FGAd/EGFP respectively and analyzed EGFP expressing level by flow cytometry. Consequently, the fluorescent expression rate and fluorescent intensity of EGFP were higher in early infected A549 cells by HDAd/EGFP than by FGAd/EGFP. HDAd, capable of expressing transgene instantly and efficiently in vitro, is a potential vaccine vector.
Adenoviridae
;
genetics
;
metabolism
;
Cell Line, Tumor
;
Genetic Vectors
;
genetics
;
Green Fluorescent Proteins
;
genetics
;
Helper Viruses
;
genetics
;
metabolism
;
Humans
;
Transgenes
;
Viral Fusion Proteins
;
genetics
;
metabolism
7.Construction of replication-deficient recombinant adenovirus vector with hTFPI-2 gene by AdMax system and expression in U937 monocytes in vitro.
Junjie PAN ; Haiming SHI ; Xinping LUO ; Duan MA ; Wang LIANG ; Jin ZHANG ; Jun ZHU ; Jian LI
Journal of Biomedical Engineering 2011;28(2):326-331
We tried to construct and identify the recombinant replication-deficient adenovirus vector coding for human tissue factor pathway inhibitor 2 (hTFPI-2) gene by AdMax system in HEK293 cells. Firstly, we obtained hTFPI-2 gene from the recombinant plasmid pIRES2-EGFP-TFPI-2 by PCR using primers with restriction endonuclease site of EcoRI or SacI. After digesting the hTFPI-2 gene and plasmid PDC316-IRES-EGFP shuttle vector, we ligated them with T4 ligase and formed the recombinant shuttle vector PDC316-IRES-EGFP-hTFPI-2. It was confirmed that the ligation product was inserted the gene of hTFPI-2 correctly by sequencing. Then we took cotransfection of HEK293 cells with the recombinant shuttle vector and genomic plasmid pBHGloxdeltaE1,3Cre by liposome lipofectamine2000, and finished the package of recombinant adenovirus Ad-hTFPI-2. The results of the PCR test and restriction endonuclease digestion confirmed the successful construction of the recombinants Ad-hTFPI-2. Furthermore, we measured the titre of Ad-hTFPI-2 with the aid of green fluorescence protein expression after multiplication and purification. The titre was 0.931 x 10(12) pfu/ml. Finally, we infected U937 monocytes by purified Ad-hTFPI-2, and determined the infection efficiency and the TFPI-2's level and activity. The efficiency of Ad-hTFPI-2 infection in U937 cells was 89.33%. After infected by Ad-hTFPI-2, the TFPI-2's level in supernatant increased about 7 fold. Also the TFPI-2 in supernatant had activities of inhibiting trypsin and plasmin. The recombinant adenovirus with the hTFPI-2 gene was constructed successfully. It will be helpful for the further investigation of its potentiality to be applied in antiatherosclerosis.
Adenoviridae
;
genetics
;
metabolism
;
Defective Viruses
;
genetics
;
metabolism
;
Genetic Vectors
;
genetics
;
Glycoproteins
;
biosynthesis
;
genetics
;
Humans
;
Monocytes
;
metabolism
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
Transfection
;
U937 Cells
8.Comparison of transduction efficiencies of various gene vectors in human bone-marrow-derived mesenchymal stem cells.
Zheng-Shan LIU ; Cheng ZHANG ; Yan-Chang SHANG ; Fu XIONG ; Shan-Wei FENG ; Yong LI ; Yong-Feng XU ; Chang ZHOU
Acta Academiae Medicinae Sinicae 2008;30(5):569-573
OBJECTIVETo compare the transduction efficiencies of adenoviral vector, adeno-associated viral vector, baculoviral vector, and plasmid vector in human bone-marrow-derived mesenchymal stem cells (hBMSCs).
METHODSThe hBMSCs were cultured in vitro and transducted with the adenoviral vector, adeno-associated viral vector, baculoviral vector, and plasmid vector. The expression of target protein was observed by inverted fluorescent microscopy and flow cytometry.
RESULTSInverted fluorescent microscopy showed that some of the hBMSCs after transduction expressed the green fluorescent protein (GFP) and the hBMSCs transducted with baculoviral vector expressed more GFP than those of other three vectors. Flow cytometry showed that the transduction efficiencies and mean fluorescence intensities of the adenoviral vector, adeno-associated viral vector, and plasmid vector were 42%, 37%, and 22% and 158, 115, and 77, respectively, which were significantly lower than those of baculoviral vector (70%, P < 0.01; 212, P < 0.05; respectively).
CONCLUSIONCompared with the adenoviral vector, adeno-associated viral vector, and plasmid vector, the baculoviral vector has higher transduction efficiency in hBMSCs and therefore may be a more suitable gene vector for research in human gene therapy.
Adenoviridae ; genetics ; metabolism ; Baculoviridae ; genetics ; metabolism ; Bone Marrow Cells ; metabolism ; virology ; Cells, Cultured ; Dependovirus ; genetics ; metabolism ; Gene Expression ; Genetic Vectors ; genetics ; metabolism ; Green Fluorescent Proteins ; genetics ; metabolism ; Hematopoietic Stem Cells ; metabolism ; virology ; Humans ; Plasmids ; genetics ; metabolism ; Transduction, Genetic ; methods
9.Preparation and characterization of Ad-ERα-36-Fc-GFP.
Yuqiong XIE ; Chunchun LI ; Xiaoye LI ; Lihong CHEN ; Maoxiao YAN ; Jiang CAO
Chinese Journal of Biotechnology 2022;38(3):1086-1095
ERα-36 is a novel subtype of estrogen receptor α which promotes tumor cell proliferation, invasion and drug resistance, and it serves as a therapeutic target. However, only small-molecule compounds targeting ERα-36 are under development as anticancer drugs at present. Gene therapy approach targeting ERα-36 can be explored using recombinant adenovirus armed with decoy receptor. The recombinant shuttle plasmid pDC316-Ig κ-ERα-36-Fc-GFP was constructed via genetic engineering to express an Ig κ-signaling peptide-leading secretory recombinant fusion protein ERα-36-Fc. The recombinant adenovirus Ad-ERα-36-Fc-GFP was subsequently packaged, characterized and amplified using AdMaxTM adenovirus packaging system. The expression of fusion protein and functional outcome of Ad-ERα-36-Fc-GFP transduction were further analyzed with triple-negative breast cancer MDA-MB-231 cells. Results showed that the recombinant adenovirus Ad-ERα-36-Fc-GFP was successfully generated. The virus effectively infected MDA-MB-231 cells which resulted in expression and secretion of the recombinant fusion protein ERα-36-Fc, leading to significant inhibition of EGFR/ERK signaling pathway. Preparation of the recombinant adenovirus Ad-ERα-36-Fc-GFP provides a basis for further investigation on cancer gene therapy targeting ERα-36.
Adenoviridae/genetics*
;
Cell Proliferation
;
Estrogen Receptor alpha/metabolism*
;
Recombinant Proteins
;
Transfection
10.Construction and identification of recombinant adenovirus expressing rat proteoglycan II.
Fang WU ; Hang-ping YAO ; Feng-qin DONG
Journal of Zhejiang University. Medical sciences 2006;35(5):523-528
OBJECTIVETo construct recombinant adenovirus expressing rat proteoglycan II (Ad-DCN) and to study its biological features.
METHODSRat DCN gene was inserted into an E1 and E3-substituted adenovirus shuttle plasmid. And this shuttle plasmid including DCN was recombined with AdEasy-1 in BJ5183-AD-1 electroporation competent cells to form recombinant adenovirus-DCN plasmid, which was further transfected into Ad293 cells to passage adenovirus. The control recombinant adenovirus, Ad-LacZ, was also constructed in the same way. After plaque forming trail and adjusted with PBS, Ad-DCN and Ad-LacZ were obtained with titer 1x10(9) pfu x ml(-1). PCR, Western blot and MTT analysis were used to detect the expression of DCN or the bioactivity of expressed DCN.
RESULTDCN was detected in Ad-DCN infected CHO cells by PCR and Western blot, but not in Ad-LacZ infected CHO cells. MTT analysis results showed that the supernatant from the culture of Ad-DCN infected CHO cells could abrogate the inhibitive effect of TGFbeta1 on proliferation of CCL-64 cells. The proliferation rate of TGFbeta1 + Ad-DCN treated cells was significantly higher than that of TGFbeta1 + Ad-lacz or TGFbeta1 treated cells [(0.5252 +/-0.04 compared with 0.2826 +/-0.02 or 0.2918 +/-0.02) OD, P <0.05] and lower than that of control cells [(0.9332 +/-0.08) OD, P <0.05].
CONCLUSIONThe constructed recombinant adenovirus can express biologically active decorin.
Adenoviridae ; genetics ; metabolism ; Animals ; Genetic Vectors ; Male ; Proteoglycans ; biosynthesis ; genetics ; Rats ; Rats, Sprague-Dawley ; Recombinant Proteins ; biosynthesis ; genetics ; Recombination, Genetic